Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Schizophrenia Research
|
November 25, 2004
Plasma clozapine concentration coefficients of variation in a long-term study
Francisco J Diaz, Jose de Leon, Richard C Josiassen, et al.
The American Journal of Psychiatry
|
October 7, 2004
Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder
George M Simpson, Ira D Glick, Peter J Weiden, et al.
International Clinical Psychopharmacology
|
June 12, 2008
Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidone
Carla M Canuso, Eriene A Youssef, Cynthia A Bossie, et al.
The Journal of Clinical Psychiatry
|
May 14, 2005
An 8-week open-label trial of a 6-day course of mifepristone for the treatment of psychotic depression
George M Simpson, Adel El Sheshai, Nasser Loza, et al.
Journal of Clinical Psychopharmacology
|
November 13, 2004
Haloperidol half-life after chronic dosing
Jose de Leon, Francisco J Diaz, Peter Wedlund, et al.
Schizophrenia Research
|
April 6, 2004
Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia
Philip D Harvey, Herbert Meltzer, George M Simpson, et al.
Journal of Clinical Psychopharmacology
|
August 16, 2003
Serum antimuscarinic activity during clozapine treatment
Jose de Leon, Aruby Odom-White, Richard C Josiassen, et al.
The Journal of Clinical Psychiatry
|
September 13, 2006
A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder
George M Simpson, Ramy A Mahmoud, Robert A Lasser, et al.
Annals of General Psychiatry
|
January 31, 2007
Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended dosing interval
Georges M Gharabawi, Natalie C Gearhart, Robert A Lasser, et al.
Schizophrenia Bulletin
|
August 12, 2003
The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development
T Scott Stroup, Joseph P McEvoy, Marvin S Swartz, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Schizophrenia Research
|
November 25, 2004
Plasma clozapine concentration coefficients of variation in a long-term study
Francisco J Diaz, Jose de Leon, Richard C Josiassen, et al.
The American Journal of Psychiatry
|
October 7, 2004
Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder
George M Simpson, Ira D Glick, Peter J Weiden, et al.
International Clinical Psychopharmacology
|
June 12, 2008
Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidone
Carla M Canuso, Eriene A Youssef, Cynthia A Bossie, et al.
The Journal of Clinical Psychiatry
|
May 14, 2005
An 8-week open-label trial of a 6-day course of mifepristone for the treatment of psychotic depression
George M Simpson, Adel El Sheshai, Nasser Loza, et al.
Journal of Clinical Psychopharmacology
|
November 13, 2004
Haloperidol half-life after chronic dosing
Jose de Leon, Francisco J Diaz, Peter Wedlund, et al.
Schizophrenia Research
|
April 6, 2004
Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia
Philip D Harvey, Herbert Meltzer, George M Simpson, et al.
Journal of Clinical Psychopharmacology
|
August 16, 2003
Serum antimuscarinic activity during clozapine treatment
Jose de Leon, Aruby Odom-White, Richard C Josiassen, et al.
The Journal of Clinical Psychiatry
|
September 13, 2006
A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder
George M Simpson, Ramy A Mahmoud, Robert A Lasser, et al.
Annals of General Psychiatry
|
January 31, 2007
Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended dosing interval
Georges M Gharabawi, Natalie C Gearhart, Robert A Lasser, et al.
Schizophrenia Bulletin
|
August 12, 2003
The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development
T Scott Stroup, Joseph P McEvoy, Marvin S Swartz, et al.
Page
of 4